Table: Oncolys Biopharma -9-MTH parent results

Oncolys Biopharma

04/11/2016 06:00

Nov 4 (Reuters)-  
             Oncolys Biopharma Inc.  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended        Year to    
                Sep 30, 2016        Sep 30, 2015       Dec 31, 2016   
                   LATEST             YEAR-AGO            LATEST      
                   RESULTS             RESULTS           FORECAST     
  Sales            46 mln              19 mln            188 mln      
                (+133.5 pct)        (+179.7 pct)       (+55.5 pct)    
  Operating     loss 679 mln        loss 698 mln       loss 897 mln   
  Recurring     loss 682 mln        loss 599 mln       loss 900 mln   
  Net           loss 731 mln        loss 601 mln       loss 949 mln   
  EPS          loss 79.53 yen      loss 65.46 yen    loss 102.85 yen  
  Ann Div                                NIL               NIL        
  -Q2 div            NIL                 NIL                          
  -Q4 div                                NIL               NIL        
   
  NOTE - Oncolys Biopharma Inc..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T  
  ((Tokyo Headline News Desk +813 6441 1812))